Skip to main content

Mayo Clinic Update

The Nephrology Department of the Portuguese Institute of Oncology of Porto (IPO-Porto) will organize jointly with the Nephrology Department of the Mayo Clinic, Rochester, USA, a scientific meeting called Mayo Clinic Update, Oporto 2024, 14th and 15th June, as part of the celebrations of IPO-Porto’s 50th anniversary. This event will take place in the Auditorium of the Super Bock Arena Complex – Pavilhão Rosa Mota.

Until March 15th



  • Access to Lectures
  •  Documentation Folder
  • Lunch
  • Coffee Break
  • Certificate of Attendance

Until March 15th



  • Access to Lectures
  •  Documentation Folder
  • Lunch
  • Coffee Break
  • Certificate of Attendance

From March 16th to May 31st
€ 100,00
From March 16th to May 31st
Non Member
€ 200,00

* must be a member to one of the following societies
Sociedade Portuguesa de Nefrologia
Sociedad Española de Nefrologia
Sociedade Brasileira de Nefrologia
Sociedade Portuguesa de Medicina Interna

Attendance limited to auditorium capacity


Complement-mediated Thrombotic Microangiopathy (CM-TMA) / Atypical Hemolytic Syndrome
Ann M. Moyer, M.D., Ph.D.
Lupus Nephritis (What’s new?)
Ali Duarte Garcia, M.D., PhD.
ANCA Vasculitis: Novel, more effective and safer treatment modalities
Ulrich Specks, M.D.,P.I.
ANCA Vasculitis – Towards personalized medicine
Marta Casal Moura, M.D., Ph.D.
Diagnosis and treatment of Membranous Nephropathy
Fernando Fervenza, M.D., Ph.D.
New antigens in Membranous Nephropathy
Fernando Fervenza, M.D., Ph.D.
An update on the classification and diagnosis of Monoclonal Gammopathy of Renal Significance lesions
Samih Nasr, M.D.
Current approaches in treatment of Monoclonal Gammopathy of Renal Significance
Ladan Zand, M.D.
Genetics and Kidney Diseases
Filippo Pinto e Vairo, M.D., Ph.D.
Autosomal Dominant Polycystic Kidney Disease in 2024
Vicente Torres, M.D., Ph.D.
SGLT2 Inhibitors and the Kidney
Maria José Soler, M.D., Ph.D.
Renal Disease in Pregnancy
Vesna Garovic, M.D., Ph.D.
Artificial Intelligence to guide management of Acute Kidney Injury
Kianoush Kashani, M.D., M.S.
New drugs and perspectives for the treatment of Kidney Diseases in 2024
Emílio Sánchez, M.D, Ph.D.
Nephrotoxicity of Immune Checkpoint Inhibitors
Sandra Herrmann, MD
Mult’Itox Consultation: A multidisciplinary approach to optimize the immune effetcs of Checkpoint inhibitors
Teresa Chuva, MD
Chimeric antigen receptor (CAR) - T cell therapy in Cancer patients
José Mário Mariz, MD
CAR-T cells therapy: Nephrotoxicity and future use for autoimmune diseases
Sandra Herrmann, MD
Clinical Pathology cases: chosen among the submitted abstracts
2 sessions of 4 clinical cases (1 session per day)
Samih Nasr, Fernando Fervenza, José Maximino

Rulles for Abstracts Submission

The abstracts must correspond to clinical-pathological cases.

01. Structure

The Abstract Template at the end of this page must be used. Please download it and fill out keeping the structure and examples:
Title of abstract; name and surname; workplace of the authors and email;

The abstract must not identify any of the authors or any other details that could compromise anonymity.
It must be submitted in English; containing a maximum of 3.400 characters (spaces included). The introduction of one image is allowed.

02. Application

Abstracts must be sent until April 15th, 2024 in Word and PDF format to:
The organization will select the 8 most relevant cases. All authors will be notified by this decision until May 13th.
At least one of the authors must be registered at the congress.

03. Format

The 8 selected cases will be orally presented (10 minutes for presentation, 5 minutes for discussion) in a session at the end of each day.
Upon notification of the authors, a Powerpoint template will be sent for oral presentation, as well as other relevant information.



Scientific Sponsors


Coming Soon
Coming Soon
Coming Soon

Super Bock Arena

Pavilhão Rosa Mota

The Super Bock Arena – Pavilhão Rosa Mota is a multi-purpose space, equipped with the most modern technologies, with capacity for cultural, entertainment, sporting and business events for up to 8,000 people

Rua de Dom Manuel II, 4050-346 Porto

(+351) 220 503 257

Ligia Silva

(+351) 914 592 380